Companies /Healthcare

Pacira BioSciences Inc

NASDAQ: PCRX Drug Manufacturers - Specialty & Generic
$25.75
▼ $0.15 (−0.58%) today
Markets open · 2:17pm ET
Today · % change

Fundamentals

Market Cap
$1.0B
P/E Ratio
74.0
Profit Margin
2.0%
Revenue (TTM)
$746.2M
EPS (TTM)
$0.35
52-Week Range
$19 – $28
Street Target
$30.00

About Pacira BioSciences

Pacira BioSciences Inc specializes in creating non-opioid pain management and regenerative health solutions. Their product lineup includes EXPAREL, a pain relief injectable, ZILRETTA, an extended-release injection for managing osteoarthritis pain, and the iovera system, a device offering temporary pain relief through cold therapy. The company, rooted in innovation for safer pain management, also collaborates on NOCITA, another pain relief injectable. Founded in 2006 and based in Tampa, Florida, Pacira is committed to reducing reliance on opioids in healthcare.

PCRX Coverage